192 related articles for article (PubMed ID: 18922643)
1. Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
Hunter RJ; Navo MA; Thaker PH; Bodurka DC; Wolf JK; Smith JA
Cancer Treat Rev; 2009 Feb; 35(1):69-78. PubMed ID: 18922643
[TBL] [Abstract][Full Text] [Related]
2. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Griggs JJ; Mangu PB; Anderson H; Balaban EP; Dignam JJ; Hryniuk WM; Morrison VA; Pini TM; Runowicz CD; Rosner GL; Shayne M; Sparreboom A; Sucheston LE; Lyman GH;
J Clin Oncol; 2012 May; 30(13):1553-61. PubMed ID: 22473167
[TBL] [Abstract][Full Text] [Related]
3. The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.
Hansen J; Stephan JM; Freesmeier M; Bender D; Button A; Goodheart MJ
Gynecol Oncol; 2015 Jul; 138(1):154-8. PubMed ID: 25958318
[TBL] [Abstract][Full Text] [Related]
4. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
Schwartz J; Toste B; Dizon DS
Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
[TBL] [Abstract][Full Text] [Related]
6. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
[TBL] [Abstract][Full Text] [Related]
7. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
[TBL] [Abstract][Full Text] [Related]
8. Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.
Horowitz NS; Wright AA
Gynecol Oncol; 2015 Jul; 138(1):201-6. PubMed ID: 25870918
[TBL] [Abstract][Full Text] [Related]
9. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
[TBL] [Abstract][Full Text] [Related]
10. Body surface area estimation in children using weight alone: application in paediatric oncology.
Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.
Lucas CJ; Martin JH
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S78-S98. PubMed ID: 28921641
[TBL] [Abstract][Full Text] [Related]
12. Dosing considerations for obese patients receiving cancer chemotherapeutic agents.
Hall RG; Jean GW; Sigler M; Shah S
Ann Pharmacother; 2013 Dec; 47(12):1666-74. PubMed ID: 24259627
[TBL] [Abstract][Full Text] [Related]
13. Obesity and chemotherapy administration: between empiric and mathematic method review.
Bouleftour W; Mery B; Chanal E; Rowinski E; Viard A; Forges F; Fournel P; Rivoirard R
Acta Oncol; 2019 Jun; 58(6):880-887. PubMed ID: 30907190
[No Abstract] [Full Text] [Related]
14. Dosing of chemotherapy in obese and cachectic patients: results of a national survey.
Anglada-Martínez H; Riu-Viladoms G; do Pazo-Oubiña F; Molas-Ferrer G; Mangues-Bafalluy I; Codina-Jané C; Creus-Baró N
Int J Clin Pharm; 2014 Jun; 36(3):589-95. PubMed ID: 24771403
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy dosing in overweight and obese patients with cancer.
Lyman GH; Sparreboom A
Nat Rev Clin Oncol; 2013 Aug; 10(8):451-9. PubMed ID: 23856744
[TBL] [Abstract][Full Text] [Related]
16. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
[TBL] [Abstract][Full Text] [Related]
17. Body surface area for adjustment of drug dose.
Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.
Thimotheo Batista JP; Santos Marzano LA; Menezes Silva RA; de Sá Rodrigues KE; Simões E Silva AC
Curr Med Chem; 2023; 30(9):1003-1028. PubMed ID: 35946096
[TBL] [Abstract][Full Text] [Related]
19. Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.
Portugal RD
Med Hypotheses; 2005; 65(4):748-51. PubMed ID: 15979816
[TBL] [Abstract][Full Text] [Related]
20. Body surface area as a determinant of pharmacokinetics and drug dosing.
Sawyer M; Ratain MJ
Invest New Drugs; 2001 May; 19(2):171-7. PubMed ID: 11392451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
